Intuitive Surgical raises guidance on strong commercial momentum

Published: 2026-04-22 11:15:44 ET ISRG

Surgical robotics specialist Intuitive Surgical has announced an upward revision to its 2026 outlook following Q1 that exceeded expectations. The group now forecasts procedure growth between 13.5% and 15.5%, up from the previous range of 13% to 15%. According to management, this performance is driven by continued momentum in general surgery in the US and the expansion of non-urology procedures internationally. The stock is trading up 8% in today's session.

Esteban Tesson

Published on 04/22/2026 at 11:15 am EDT

Quarterly results reflect this momentum, with adjusted EPS of $2.50, compared to $1.81 a year ago, beating forecasts of $2.12. Revenue grew by 23% to reach $2.77bn. Instruments and accessories revenue reached $1.69bn, up 23%, supported by an approximately 16% increase in da Vinci procedures and a 39% jump for the Ion system.In detail, procedures grew by 15% in the US and 20% internationally, while system sales reached $650.7m with 431 units installed, compared to 367 a year ago. Service revenue amounted to $433.7m. Furthermore, the group anticipates an adjusted gross margin between 67.5% and 68.5%, despite a negative impact of approximately 1% related to tariffs.